首页> 外文期刊>Oxidative Medicine and Cellular Longevity >Bioactive Compounds of Raspberry Oil Emulsions Induced Oxidative Stress via Stimulating the Accumulation of Reactive Oxygen Species and NO in Cancer Cells
【24h】

Bioactive Compounds of Raspberry Oil Emulsions Induced Oxidative Stress via Stimulating the Accumulation of Reactive Oxygen Species and NO in Cancer Cells

机译:覆盆子油乳液的生物活性化合物通过刺激反应性氧物种的积累和癌细胞中的含量诱导氧化胁迫

获取原文
           

摘要

There are growing interests in the complex combinations of natural compounds that may advance the therapy of cancer. Such combinations already exist in foods, and a good representative is seed oils. Two raspberry oils: cold pressed (ROCOP) and one extracted by supercritical CO 2 (ROSCO2) were evaluated for their chemical characteristics and oil emulsions for cell suppression potential against colon adenocarcinoma (LoVo), doxorubicin-resistant colon adenocarcinoma (LoVo/DX), breast cancer (MCF7), doxorubicin-resistant breast cancer (MCF7/DX), and lung cancer (A549) cell lines. The cytotoxicity was also assessed on normal human dermal fibroblasts (NHDFs). With increasing concentration of raspberry oil emulsions (0.5–10%), increasing inhibition of cancer cell viability and proliferation in all of the lines was observed, with different degrees of potency between cancer types and oil tested. ROSCO2 strongly induced free radical production and DNA strand damage in LoVo and MCF7 cells especially doxorubicin-resistant lines. This suggests that ROSCO2 engages and effectively targets the vulnerabilities of the cancer cell. Generally, both ROSCO2 and ROCOP could be a nontoxic support in therapy of selected human cancers.
机译:在可能提高癌症治疗的自然化合物的复杂组合中存在越来越兴趣。这种组合已经存在于食物中,并且良好的代表是种子油。两种覆盆子油:冷压(rocop)和由超临界CO 2(Rosco2)提取的一种(Rosco2)的化学特性和油乳液,用于对Colon腺癌(Lovo),多柔枯蛋白型结肠腺癌(Lovo / DX)进行细胞抑制潜力,乳腺癌(MCF7),抗乳蛋白抗性乳腺癌(MCF7 / DX)和肺癌(A549)细胞系。还在正常人体皮肤成纤维细胞(NHDF)上评估细胞毒性。随着覆盆子油乳液浓度的增加(0.5-10%),观察到癌细胞活力和癌细胞活力和增殖的抑制,在癌症类型和石油之间具有不同程度的效力。 ROSCO2强烈诱导了LOVO和MCF7细胞中的自由基生产和DNA链损伤,特别是多柔比蛋白抗性线。这表明Rosco2从事并有效地瞄准癌细胞的脆弱性。通常,罗斯科2和罗科均可是对选定人类癌症的治疗中的无毒支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号